tickstock newsroom AI
Articles
Literacy Capital sells largest fund interest for €5.7m, accelerates shift to direct buyouts
It has sold its largest third-party fund interest for €5.7m at par, cutting exposure to third-party funds and freeing cash for bolt-on purchases.
Physiomics secures more modelling and data-science contracts
It won multiple new and follow-on UK and international contracts to provide modelling, biometrics and data-science support across Phase 1-2 clinical programmes, with revenue visible through to the end of 2027.
Zotefoams shares rise thanks to four-month revenue rise
"We remain confident in delivering our full‑year objectives, supported by a strong balance sheet and continued demand across our key target markets," said Ronan Cox, Group CEO.
Hollywood Bowl Group shares climb as H1 revenue growth instills confidence
"Looking ahead, we are confident in delivering on expectations for FY26, as customer appeal for our value offer remains robust, and we continue to maintain a tight grip on costs," said Stephen Burns, Chief Executive Officer.
Nanoco Group shares crashed after delisting proposal
Nanoco Group plans to cancel its Main Market listing and re-register as a private company to cut costs, preserve cash and pursue commercialisation away from public-market disclosure requirements.
Jangada Mines confirms high‑grade gold at Molly, extends mineralised strike
It reported high‑grade gold, silver and copper assays from its Molly Gold Project in Brazil that extends the known mineralised corridor and underpins a funded expansion of drilling.
Gresham House Energy Storage Fund inks exclusivity deal with Summit Transition Partners
The exclusivity arrangement with a JV between Sumitomo Corporation and TPK Holdings, will see the partner pick up stakes in UK battery projects, and provide equity funding to enable immediate construction.
Kendrick Resources assigns US$400m NPV to Teufelskuppe rare‑earth project
Andrada Mining secures loans from Namibian banks, completes expanded Lithium Ridge drilling with SQM partner
Andrada Mining has conditionally agreed senior secured term loans from Bank Windhoek and the Development Bank of Namibia and announced it has finished an expanded diamond‑drilling programme at its Lithium Ridge project.
Afentra confirms stake in new licence onshore Angola
The oil and gas junior has been awarded a 35% operated interest in onshore Block KON4, now approved by Presidential Decree, adding the large Quenguela Norte redevelopment opportunity to its Kwanza basin portfolio.
The Premarket Brief: Bodycote surges on FY26 outlook, Nanoco proposes delisting, Scottish Mortgage, Zotefoams
Bodycote its full-year outlook and flagging improved operating margins, while Nanoco Group surprised the market by proposing to delist from the London Stock Exchange entirely.
ValiRx's Cytolytix secures European patent for nanoparticle delivery
ValiRx said its majority‑owned subsidiary Cytolytix has secured European Patent EP4225803B1 for a nanoparticle system to deliver anti‑cancer peptides, a move the company says strengthens its IP estate and commercial negotiating position.
Itaconix launches deeperclean.com to market its formulated detergents
Sundae Bar reports on first half since launching live marketplace
The AIM‑listed enterprise platform said it recognised its first revenues after launching a live marketplace and an Enterprise Offering in the period.
Bodycote maintains FY26 outlook as core revenue rises
"Trading year-to-date and continued strategic progress underpin our expectation to deliver Core organic revenue growth and improved operating margins for the full year," Bodycote said.
Deltic Energy receives US$1m from Dana Petroleum under Selene farm‑out
The British small-cap offshore oil explorer received the cash relating to costs repayable under a farm‑out deal for the Selene Prospect.
Watkin Jones revenue falls to £100.2m as activity slows
"Our integrated platform continues to be a key differentiator, enabling us to identify incremental opportunities to deploy capabilities and diversify revenues," Alex Pease said.
AstraZeneca says FDA extends decision date for camizestrant, allowing extra data review
The US Food and Drug Administration has extended the Prescription Drug User Fee Act decision date for AstraZeneca's camizestrant combination filing to permit review of additional analyses requested for the SERENA-6-based NDA.
Pets at Home says its comfortable about expectations, despite drop in profits
"We have the opportunity now to build momentum through profitable volume led growth in Retail while continuing to execute the proven growth levers of our Vet business and launch our Insurance offering," said James Bailey, Chief Executive Officer.